§01 Browse › Clomiphene

Clomiphene

Clomid Clomiphene Citrate

None

Technical catalog description

Clomiphene citrate is a selective estrogen receptor modulator (SERM) used primarily for PCT to restart natural testosterone production. It works by blocking estrogen receptors in the hypothalamus and pituitary, leading to increased release of LH and FSH.

Clomiphene is often considered more potent than Tamoxifen for testosterone recovery, but it can cause more pronounced mood-related side effects including emotional lability, depression, and visual disturbances in some users.

Overview Use context Comparison Safety
Warning
Can cause mood swings and emotional lability · May cause visual disturbances at higher doses · Can worsen depression in susceptible individuals

Read next

The Philosophy and Practice of Harm Reduction 9 min read
More depthTren, Nandrolone, Prolactin, and 19-Nor MythsSARMs, Prohormones, and Novel CompoundsBefore You Decide to Use Anabolic Steroids
Overview
Mechanism details

Clomiphene citrate is a SERM with a different receptor binding profile than Tamoxifen. It stimulates LH and FSH release more potently than tamoxifen at comparable doses, making it the stronger choice for users who need a harder HPTA restart. However, its tolerability profile is meaningfully worse: mood instability, emotional lability, anxiety, and visual disturbances (light sensitivity, halos, afterimages) occur in a significant minority of users.

The visual disturbances are worth taking seriously. While typically reversible, persistent visual changes on clomiphene require stopping the compound. Continuing through visual symptoms is not recommended.

Clomiphene exists as two isomers: enclomiphene (the active isomer for LH/FSH stimulation) and zuclomiphene (which is estrogenic and responsible for many of the mood effects). Pharmaceutical-grade clomiphene contains both. Enclomiphene as an isolated compound is sometimes available and has a better tolerability profile, though it is less commonly accessible.

Safety & monitoring
Side effects

  • Emotional lability, anxiety, and visual disturbances

  • Some users feel worse on it even while testosterone markers improve

Monitoring

  • Total testosterone, LH, and FSH if used for PCT

  • Mood and visual tolerance

Avoid if

  • History of major visual disturbance or poor psychiatric tolerance to SERMs

  • Long-term use when tamoxifen or a simpler plan would do the job

Use context

Clomiphene is chosen when a stronger LH/FSH push is warranted, typically after a long, heavily suppressive cycle where tamoxifen alone may not produce sufficient recovery speed. It is also used when prior PCT attempts with tamoxifen alone produced incomplete recovery.

Unverified community-use description: Clomiphene and tamoxifen are discussed together in recovery protocols. This catalog does not validate their amounts, combination, or treatment duration.

Common mistakes

Staying on clomiphene through significant mood or visual side effects. This profile does not establish a dose adjustment or substitute medication for that situation.

Using clomiphene as a standard PCT protocol. This catalog does not establish a recovery regimen for either mild or prolonged suppression.

Assuming longer is better for recovery speed. PCT length is driven by lab confirmation of recovery, not by compound duration.

Comparison notes

Compared with Tamoxifen, clomiphene produces stronger LH stimulation but significantly worse tolerability in mood-sensitive users. Tamoxifen is the first-line PCT choice for most users. Clomiphene is the escalation tool when tamoxifen is insufficient or when cycle suppression is severe enough to warrant a stronger push from the start.

Record quantities in the builder Read: The Philosophy and Practice of Harm Reduction ← Browse